📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
42
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RGNT.
💹 Market Data
Market Cap$10.26M
Shares Outstanding5.18M
Float2.82M
Cash$7.38M
Debt$1.20M
Short InterestN/A
🏛 Institutional Holdings
3 institutional holders · 281.0K shares
#1
Rosalind Advisors, Inc.
251.5K shares
#2
Warberg Asset Management LLC
19.1K shares
#3
CITADEL ADVISORS LLC
10.4K shares
📉 Short Interest
Short Interest12.5K
Days to Cover3.0
% of Float0.4%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
3
FORM3
Mar 30, 2026
3
FORM3
Mar 18, 2026
3
FORM3
Mar 18, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for RGNT
📊 RGNT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RGNT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.